AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Feb 16, 2012
30016_dirs_2012-02-16_5d56c78f-d9fa-4951-8e13-5c185d1cbe87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14
Reporting Person: FENNELL GEORGE (CORPORATE VICE PRESIDENT)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-14 | Non-Qualified Stock Option (right to buy) | $87.42 | A | 1399 | Acquired | 2019-02-13 | Common Stock (1399) | Direct |
| 2012-02-14 | Incentive Stock Option (right to buy) | $87.42 | A | 5715 | Acquired | 2019-02-13 | Common Stock (5715) | Direct |
| 2012-02-14 | Restricted Stock Unit | $ | A | 715 | Acquired | Common Stock (715) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13